Does NEMOLIZUMAB Cause Inappropriate schedule of product administration? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Inappropriate schedule of product administration have been filed in association with NEMOLIZUMAB (NEMLUVIO). This represents 1.9% of all adverse event reports for NEMOLIZUMAB.
7
Reports of Inappropriate schedule of product administration with NEMOLIZUMAB
1.9%
of all NEMOLIZUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From NEMOLIZUMAB?
Of the 7 reports, 3 (42.9%) required hospitalization.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEMOLIZUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does NEMOLIZUMAB Cause?
Pemphigoid (51)
Death (33)
Erythema (26)
Dermatitis exfoliative generalised (25)
Erythema multiforme (25)
Dermatitis atopic (23)
Pneumonia (14)
Blister (12)
Cellulitis (12)
Eczema herpeticum (12)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
Which NEMOLIZUMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
NEMOLIZUMAB vs NEMOLIZUMAB-ILTO
NEMOLIZUMAB vs NEOMYCIN
NEMOLIZUMAB vs NEORAL
NEMOLIZUMAB vs NEOSTIGMINE
NEMOLIZUMAB vs NEOSTIGMINE METHYLSULFATE